Bronchial Asthma Clinical Trial
Official title:
Assessment of the Severity of Acute Asthma Exacerbation in Children Attending the Emergency Departments to Predict Outcomes by Modified Pulmonary Index Score
Asthma is a heterogeneous disease, usually characterized by chronic airway inflammation. It
is defined by the history of respiratory symptoms such as wheeze, shortness of breath, chest
tightness and cough that vary over time and in intensity, together with variable expiatory
airflow limitation. This definition was reached by consensus, based on consideration of the
characteristics that are typical of asthma and that distinguish it from other respiratory
conditions .
Asthma is a problem worldwide, with an estimated 300 million affected individuals .It
appears that the global prevalence of asthma ranges from 1% to 18% of the population in
different countries .
Over the past years, an increase in the number of emergency department (ED) visits for
asthma exacerbation has been reported. Most of these visits are for preschool children.
Although pulmonary function tests are commonly used to assess the severity of acute asthma
in adults, they are difficult to perform in children, especially those who are younger than
five years old .
spirometry measures pulmonary markers such as vital capacity and maximal forced expiatory
volume in 1 second. Well-trained personnel are required to perform these tests, and they are
not routinely available in the ED. Peak flow has been used in the ED to measure the degree
of respiratory obstruction .This technique is difficult to perform in children less than 6
years of age because of their lack of coordination and comprehension .
Adequate evaluation of the severity of asthma exacerbation is important for the initial
management of patients, as well as for assessing the clinical response. However, severity is
more difficult to assess in children. The clinical evaluation and physician's experience are
often not enough to determine the degree of respiratory obstruction .
In the emergency room setting, the most critical issue facing the attending physician is,
deciding the adequacy of outpatient therapy of acute asthma, or when hospitalization is
indicated. Traditionally, this decision is used to be made according to the clinical
history, physical examination, laboratory results and response to therapy of the patient .
A number of asthma severity measures or scoring systems have been established to estimate
the degree of airway obstruction for children in whom the standard measurements cannot be
performed. These systems combine a number of physical signs, such as respiratory rate and
accessory muscle use, to form an aggregate score that estimates the severity of an acute
asthma exacerbation .no scoring system is perfect, but some method of assessing severity in
children is needed when spirometry testing is not obtainable.
modified the pulmonary index was reported by adding 2 scoring items, namely heart rate and
SpO2 at room temperature, and by dividing the method of heart rate and respiratory rate
scoring depending on which of 2 age groups the patient belong to. Modified Pulmonary Index
Score is a quantitative method of evaluating respiratory conditions in asthmatic subjects
modified and consists of 6 evaluation items, which are important for the assessment of
dyspnea and are relatively easy to assess in clinical practice, namely heart rate,
respiratory rate, accessory muscle use, inspiratory to expiatory flow ratio, degree of
wheezing, and oxygen saturation in room air.
the predictive validity and reproducibility of the Modified Pulmonary Index Score for asthma
exacerbation was reported in 30 children with a mean age of 7.6 ± 5.5 years in 2005. They
found good correlations of the Modified Pulmonary Index Score with clinical outcomes such as
ICU admission. The Modified Pulmonary Index Score appears to be suitable for measuring the
severity of acute asthma exacerbation, and was applied as primary outcome measurement in
some clinical trials .
A significant correlation between Modified Pulmonary Index Score at hospitalization and
hospitalization period in children above 5 years old, suggesting that Modified Pulmonary
Index Score was useful for predicting the clinical course after hospitalization. However,
its applicability to preschool children has not yet been fully elucidated.
The Modified Pulmonary Index Score can be a useful tool for several aspects during acute
asthma attacks, including the determination of a treatment plan, and prediction of the
period of hospitalization in admitted patients .
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02934945 -
Treatment Efficacy of Budesonide/Formoterol in Cough Variant Asthma and Typical Asthma Patients
|
Phase 4 | |
Completed |
NCT02561351 -
Correlation Between Fractional Exhaled Nitric Oxide (FeNO) Levels and Asthma Exacerbation
|
N/A | |
Recruiting |
NCT01759472 -
Effect Study of Montelukast to Treat Asthma Detected by LTD4 Bronchial Effect Study of Montelukast to Treat Asthma Detected by LTD4 Bronchial Provocation Test
|
N/A | |
Completed |
NCT01918293 -
Self-Management Using Smartphone Application for Chronic Disease Care in Real siTuation (SMART-Asthma): Adult
|
N/A | |
Completed |
NCT01203904 -
Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation
|
N/A | |
Completed |
NCT00536731 -
Symbicort Rapihaler Therapeutic Equivalence Study
|
Phase 3 | |
Completed |
NCT01762917 -
Influence of Bag Volume Variation on the Reproducibility of Inert Gas Rebreathing
|
N/A | |
Completed |
NCT00930826 -
Childhood Asthma and Schooling: The Truth Unveiled
|
N/A | |
Completed |
NCT00331929 -
Respiratory Health Study of Children in Kiryat Tivon
|
N/A | |
Completed |
NCT00327028 -
Study of Efficacy of Phenytoin in Therapy of Patients With Bronchial Asthma
|
Phase 4 | |
Completed |
NCT00413387 -
Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)
|
Phase 3 | |
Completed |
NCT00950794 -
Study of Salmeterol (SN408D) for Adult Asthma
|
Phase 4 | |
Completed |
NCT00153283 -
Study of Efficacy of Gabapentin in Therapy of Bronchial Asthma
|
Phase 4 | |
Completed |
NCT00142025 -
Study of Efficacy of Oxcarbazepine in Therapy of Bronchial Asthma
|
Phase 4 | |
Completed |
NCT00153270 -
Study of Efficacy of Sodium Valproate in Therapy of Bronchial Asthma
|
Phase 4 | |
Completed |
NCT03450434 -
XC8 in the Treatment of Patients With Bronchial Asthma
|
Phase 2 | |
Recruiting |
NCT05189613 -
Mepolizumab Effectiveness in Severe Eosinophilic Asthma and Bronchiectasis
|
N/A | |
Recruiting |
NCT04128111 -
Study on the Correlation Between TCM Syndrome, Inflammatory Phenotype and Biomarker of Bronchial Asthma
|
||
Completed |
NCT06326632 -
Comparative Effectiveness Study of Constant-Load Versus Graded Aerobic Exercise in Obese Children With Bronchial Asthma
|
N/A | |
Completed |
NCT05088512 -
The Role of Genetic Factors in the Development of Bronchial Asthma in the Kazakh Population
|